LINC00877

Across TCGA pan-cancer cohorts, LINC00877 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated LINC00877 data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher LINC00877 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated LINC00877 expression acts as an unfavorable survival marker, although some lineages such as HNSC and CESC show a favorable association.

HNSC, CESC, and LUAD are the cancer types where LINC00877 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Tertile	All	0.462	0.270	<.001	126	view →
CESC	OS	Median	All	0.872	0.729	.001	48	view →
LUAD	OS	Quartile	All	0.506	0.238	<.001	44	view →
SKCM	DFS	Quartile	All	0.699	0.576	.004	36	view →
LAML	DFS	Quartile	All	0.274	0.603	<.001	30	view →
DLBC	DFS	Quartile	III,IV	0.943	0.157	.010	29	view →
KIRP	DFS	Quartile	III,IV	0.119	0.615	.022	22	view →
SARC	DFS	Median	All	0.711	0.458	<.001	20	view →
LUSC	DFS	Median	II,III,IV	0.278	0.455	.015	19	view →
STAD	DFS	Quartile	All	0.452	0.648	.010	18	view →
ESCA	DFS	Tertile	II,III,IV	0.448	0.237	.008	18	view →
THCA	DFS	Tertile	II,III,IV	0.649	0.864	.017	17	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

LINC00877–HNSC (DFS)

Open the HNSC breakdown →